Updated Date: Thu, 24 Sep 2020 00:00:00 EDT
Category: Uncategorized
US Food and Drug Administration broadens investigation into serious adverse event
Fast track designation is based on promising phase Ib results
Diagnostics: Recovery and Renewal report identifies a number of key actions
Researchers have developed a new compound for treating cancer. It destroys a protein that triggers its development.
Figures showing that a million women in the UK missed mammograms after breast screening programmes were paused in […]
Key messagesGreenhouse gas emissions from healthcare are substantial, and the health sector has generally lagged most other industries […]
Sixfold Bioscience snares UK grant to test cancer-fighting siRNA delivery system fkansteiner Thu, 10/01/2020 – 07:46
Tennessee packaging company drops $21M into ‘state-of-the-art’ facility for push into cold chain, biologics kblankenship Thu, 10/01/2020 – […]
